April 1, 2020 Clinical Research/Diagn. Product Launch

Miltenyi Biotec launches new tool for coronavirus-specific T cell research

Specially developed research-grade PepTivator® Peptide Pools for SARS-CoV-2BERGISCH GLADBACH, April 01, 2020 – Miltenyi Biotec today launches the SARS-CoV-2 PepTivator Peptide Pools, a new addition to its popular PepTivator Portfolio specifically developed to help researchers currently investigating COVID-19. Based on decades worth of experience in developing products for virus-specific T cell research, SARS-CoV-2 PepTivator Peptide... Read more

April 1, 2020 Clinical Research/Diagn. Life Science Tools

SCIEX Debuts Breakthrough Method for Gene Therapies

Robust high-resolution determination of full, partial and empty capsid ratios for adeno-associated virus analysis April 01, 2020 Framingham, MA — SCIEX, a global leader in life science analytical technologies, launched an exciting new method for streamlining and improving the production of gene therapies. This innovative capillary electrophoretic method addresses a key customer challenge by analyzing AAVs... Read more

March 31, 2020 Clinical Research/Diagn. Product Launch

BD, BioMedomics Announce Launch of Rapid Serology Test to Detect Exposure to COVID-19

Point-of-care blood test detects evidence of present or past exposure in 15 minutesMar 31, 2020 FRANKLIN LAKES, N.J. MORRISVILLE, N.C., March 31, 2020 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioMedomics, a privately held, North Carolina-based clinical diagnostics company, today announced the release of a new point-of-care... Read more

March 30, 2020 Clinical Research/Diagn. M&A, Partnerships

Promega Part of New Wisconsin Public-Private Partnership to Increase COVID-19 Laboratory Testing Capacity

Madison, WI USA. (March 30, 2020) Promega Corporation is part of a new public-private partnership among Wisconsin industry leaders to increase the state’s laboratory testing capacity for COVID-19. Wisconsin Governor Tony Evers made the announcement today. The expanded capacity from this new partnership is expected to initially double testing capacity in Wisconsin, currently averaging 1,500-2,000 COVID-19 tests... Read more

March 26, 2020 Clinical Research/Diagn. Lab Top-10 PR/Corporate

Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19

Thermo Fisher Scientific Receives CE Mark for its Diagnostic Test to Detect COVID-19 WALTHAM, Mass., March 26, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has received the CE mark in the European Union for its diagnostic test to detect nucleic acid from SARS-CoV-2, the... Read more

March 25, 2020 Clinical Research/Diagn. Lab Top-10 Liq. Handling & Robotics Microscopy

EUROIMMUN is one of first European manufacturers of diagnostic tests to provide CE-marked antibody detection systems to support COVID-19 diagnostics

The Anti-SARS-CoV-2 ELISAs for immunoglobulin classes A and G from EUROIMMUN, a PerkinElmer, Inc.  company (NYSE:PKI), have received the CE mark and can now be applied to COVID-19 diagnostics. The PCR test EURORealTime SARS-CoV-2 has been submitted for CE mark. COVID-19 is currently significantly affecting the lives of people worldwide. At the end of January... Read more

March 19, 2020 Bio/Pharma/CRO Clinical Research/Diagn. Microscopy

Roche initiates Phase III clinical trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 pneumonia

Basel, 19 March 2020- Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced  we are working with the Food & Drug Administration (FDA) to initiate a randomised, double-blind, placebo-controlled Phase III clinical trial in collaboration with the Biomedical Advanced Research and Development Authority (BARDA), a part of the US Health and Human Services Office of the... Read more

March 17, 2020 Clinical Research/Diagn. Liq. Handling & Robotics Product Launch

Hamilton Announces Automated Coronavirus (COVID-19) Testing Workstations and Priority Fast Tracking for Any Orders Related to Combatting the Viral Pandemic

March 17, 2020 Automation Solutions and Services to Aid Critical Coronavirus Testing Reno, Nevada, USA and Bonaduz, Switzerland (March 17, 2020) – Today, Hamilton Company announces multiple automation-related initiatives to aid healthcare workers and researchers as they battle the coronavirus (COVID-19) pandemic. Two new automated assay ready workstations, based on the Company’s Microlab® STARlet liquid handling workstation, facilitate... Read more

March 16, 2020 Clinical Research/Diagn.

BD, BioGX Announce FDA Emergency Use Authorization Submissions for New COVID-19 Diagnostics for Use in U.S.

New Diagnostics Have Potential to Increase Capacity of COVID-19 Testing in U.S. by Thousands of Tests Per DayMar 16, 2020 FRANKLIN LAKES, N.J. and BIRMINGHAM, Ala. March 16, 2020 /PRNewswire/ — BD (Becton,Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and BioGX Inc, a molecular diagnostics company, today announced that the companies have... Read more